Kevin Helash

This profile gathers the share dealings of Kevin Helash in Marrone Bio Innovations Inc, where the filings describe the role as chief executive. Between 26 May 2021 and 12 July 2022, the trades on record add up to 5 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 14 July 2022, the filings show a transaction in Marrone Bio Innovations Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.